Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index

INTRODUCTION: Transcatheter arterial chemoembolization (TACE) is the first-line treatment for intermediate stage hepatocellular carcinoma (HCC) and prolongs survival in HCC patients. However, repeated TACE results in diminished therapeutic response. In addition, the superiority of sorafenib to TACE...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohki, Takamasa, Kondo, Mayuko, Karasawa, Yuki, Kawamura, Satoshi, Maeshima, Shuuya, Kojima, Kentaro, Seki, Michiharu, Toda, Nobuo, Shioda, Yoshinobu, Tagawa, Kazumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427139/
https://www.ncbi.nlm.nih.gov/pubmed/28389996
http://dx.doi.org/10.1007/s12325-017-0524-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427139/
https://www.ncbi.nlm.nih.gov/pubmed/28389996
http://dx.doi.org/10.1007/s12325-017-0524-9

Ejemplares similares